Altered quantitative sensory testing outcome in subjects with opioid therapy. - Test2 - elhamkhani - TriplyDB

Altered quantitative sensory testing outcome in subjects with opioid therapy.

Altered quantitative sensory testing outcome in subjects with opioid therapy.

http://www.wikidata.org/entity/Q37186811

about

The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain.Shared mechanisms for opioid tolerance and a transition to chronic pain.Self-loathing aspects of depression reduce postoperative opioid cessation rate Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon?Epigenetic regulation of spinal cord gene expression controls opioid-induced hyperalgesia.Effects of the N-methyl-D-aspartate receptor on temporal summation of second pain (wind-up) in irritable bowel syndrome.Influence of clonidine and ketamine on m-RNA expression in a model of opioid-induced hyperalgesia in mice Slow temporal summation of pain for assessment of central pain sensitivity and clinical pain of fibromyalgia patients Elevated pain sensitivity in chronic pain patients at risk for opioid misuse Opioid-induced hyperalgesia in community-dwelling adults with chronic pain Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.Opioid-independent mechanisms supporting offset analgesia and temporal sharpening of nociceptive information Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.Medical and psychological risks and consequences of long-term opioid therapy in women.Lack of correlation between opioid dose adjustment and pain score change in a group of chronic pain patients.The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males.Abdominal Pain, the Adolescent and Altered Brain Structure and Function.Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation To predict sufentanil requirement for postoperative pain control using a real-time method: A prospective observational cohort study Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.Opioid-induced hyperalgesia and burn pain.Chronic opioid therapy modifies QST changes following ketamine infusion in chronic pain patients.Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain?Opioids and Chronic Pain: Where Is the Balance?Effects of Spinal Cord Stimulation on Pain Thresholds and Sensory Perceptions in Chronic Pain Patients.Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study.Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative Affect.Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.Preprotachykinin-A gene disruption attenuates nociceptive sensitivity after opioid administration and incision by peripheral and spinal mechanisms in mice.Dexmedetomidine infusion for the management of opioid-induced hyperalgesia.Chronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic.Increased pain sensitivity in chronic pain subjects on opioid therapy: a cross-sectional study using quantitative sensory testing.Marked sexual dimorphism in 5-HT1 receptors mediating pronociceptive effects of sumatriptan.Influence of intraoperative remifentanil and sufentanil on sensory perception: a randomized trial.Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode.Prescribing opioids for chronic noncancer pain: predicting response and assessing risk factors.

P2860

Q30235485-C50186E1-9A4A-4FD2-8981-E5878E9292A6 Q30657653-17F3BA65-7697-43C3-B2B1-0610003C14FC Q33803874-AE955ED0-AA92-438F-982F-16A062AE4188 Q33851745-3424B7D1-D252-4F1F-8B76-9EF0AA33460F Q34158531-A74EA315-BC37-4CA5-A2BC-104990006D3F Q34227122-C3099F5E-686A-4E8C-A901-DEF14487A42F Q34680158-29D9C9B5-141F-40D9-8F22-FD540C6D7F9C Q35041398-A66CCFFA-7A6F-4CFC-B796-DD9D2E85467A Q35099798-AF0AE0F1-8CD3-4A6A-B1E9-FE77ADB6F4CE Q35189051-183D546D-76C6-4DDA-B009-ED74705395EB Q35607002-F1378F55-2B7E-4875-957A-4C88469722CC Q35875495-7CC00563-3599-4216-BDA0-C512D6998C72 Q35981314-F799D61E-A53C-4083-96DA-C22F104CA223 Q36038255-F6FD835D-001E-4B02-9BE8-80B34156B11A Q36709787-55BDFBEA-C2A2-4779-AB62-7316B26E9F33 Q36872096-E4D11871-265D-4C3D-8589-F43E9D9AD01E Q36912585-61502910-E59F-4C68-AFB4-CAF22587664A Q36951318-CA4EFCEA-E84F-4585-BBE0-F73BAA82CCCF Q37021812-6ECC303E-9C79-4732-9912-F794599EEA2A Q37205128-778B5723-347E-47F0-91E8-DCFBD678B0B9 Q37736976-6DF78D8B-EED6-43B7-A851-5FF2DD9F87E7 Q38059162-29C72FB9-9372-436C-BA60-5E8DBBD9AC5F Q38627481-6E6D8B1B-F1A1-4C1C-9887-2CF1EE4E59A5 Q38851461-869165E5-FAEB-4CCE-8D2A-E318EB60681A Q38979349-508C35E2-7E57-41EC-8DA0-380346AE46B7 Q38998329-39AEA61D-02EA-4DE0-9783-7C9C42DF77FF Q39188401-3DC5FDAB-24BE-406F-BCD8-A7E85B4D7E6A Q39598473-BD0F3C27-A5E9-46B1-81EF-55DDD665C5F0 Q39954962-9EE0DE6C-2CAA-4672-B992-ED170895FA15 Q41300169-5C1E903C-9DCD-4135-94EA-731009FD7CC4 Q41440089-F001332A-CCF5-48B2-AE55-CB139F671B92 Q42840099-8B9564CE-1EF7-4141-9A32-51139C595973 Q43075740-7AEDD7E3-840C-490E-8048-76885FF389ED Q44348089-CA5784B2-06C1-432A-9CB6-3987B0C82B85 Q46160367-BB342E8A-D1BF-4CCA-BDC6-C5C3492FF774 Q47377706-7D753BFD-8478-41AC-8C06-A343A060B7BA Q52728984-374B6655-61BF-4BD3-954A-9E49AE1A5813 Q54283655-97EF9227-BBD6-4A07-9538-DBAE0935CF09

P2860

Altered quantitative sensory testing outcome in subjects with opioid therapy.

http://www.wikidata.org/entity/Q37186811

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Altered quantitative sensory testing outcome in subjects with opioid therapy.

@en

Altered quantitative sensory testing outcome in subjects with opioid therapy.

@nl

type

label

Altered quantitative sensory testing outcome in subjects with opioid therapy.

@en

Altered quantitative sensory testing outcome in subjects with opioid therapy.

@nl

prefLabel

Altered quantitative sensory testing outcome in subjects with opioid therapy.

@en

Altered quantitative sensory testing outcome in subjects with opioid therapy.

@nl

P1433

Q37186811-E0148407-CCFD-4D20-B7F7-1024666BE19B

P1476

Q37186811-CBED1798-601B-4747-B228-8CEF48C64DE6

P2093

Q37186811-14850B12-5821-41DB-BA90-C3CFA71D647E

Q37186811-9AE5FFCC-29C0-424B-8367-4C79930D7606

Q37186811-A5AB60D1-F4DF-4B66-B5DF-AC34082716BF

Q37186811-BEE1D1C7-6E19-455D-B498-3BBF8E3A8187

Q37186811-D01F79F6-E0AC-4F82-92BF-080F43CAA6EA

Q37186811-D6B16355-81FC-4ACF-9B73-FDC9ADA5441B

P2860

Q37186811-087B3577-27CB-4D18-85E1-B6912DB2C75A

Q37186811-0FB16332-E7A0-4F63-828D-A4AD4682E7E0

Q37186811-1570AD90-C122-427C-B831-00D2B0B378F8

Q37186811-2E39D196-5A87-4CF8-AB57-AE2C49E71528

Q37186811-35177F6D-69B6-4253-9CF4-237B530D3742

Q37186811-39D29120-DC9E-418F-9DFE-6971D0EEDE6D

Q37186811-3C9D76EE-A5A8-41D9-877F-250CE98BB9BB

Q37186811-3CAEB4E1-5119-45C1-BF1F-7817013273B2

Q37186811-49001DD5-D69F-4BCD-911D-07A9F0FDA988

Q37186811-4D46965A-5BD8-4AA3-921E-72EA3E4534CA

P304

Q37186811-2E3C5F91-D823-4ED2-A939-A1643F8D1656

P31

Q37186811-9E46BD1E-117F-4F2F-864E-0034238F6D13

P356

Q37186811-B4B39E7D-DDA9-4E4E-80FD-1C22FCB10544

P407

Q37186811-E5476040-D87F-44C7-BF2C-3553177A8C47

P433

Q37186811-7993A0EE-B8AA-4956-BBF0-8A42737E17F1

P478

Q37186811-79E46F0E-1B1E-489F-BC84-101F1811BF9F

P577

Q37186811-3031AEEC-F48C-4DC7-85F1-919D5C2FCA21

P5875

Q37186811-F3615971-7BE5-41AB-81A7-4A4A66A30DE1

P698

Q37186811-50972337-64B5-48EE-87D6-95CA73E6ED45

P921

Q37186811-1200DE2A-8FF0-4014-87E2-A1124FBADA0F

P932

Q37186811-37B90E33-C986-4EC5-B387-6641605888F2

P356

J.PAIN.2009.01.022

P1433

P1476

Altered quantitative sensory testing outcome in subjects with opioid therapy.

@en

P2093

Charlene Malarick

http://www.w3.org/2001/XMLSchema#string

Jianren Mao

http://www.w3.org/2001/XMLSchema#string

Lindsey Seefeld

http://www.w3.org/2001/XMLSchema#string

Lucy Chen

http://www.w3.org/2001/XMLSchema#string

Mary Houghton

http://www.w3.org/2001/XMLSchema#string

Shuxing Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process

Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent

Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy

Opioid-induced hyperalgesia: a qualitative systematic review

Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine

Morphine induced allodynia in a child with brain tumour.

Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin.

Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.

Improved opioid analgesic effect following opioid dose reduction.

Opioid therapy for chronic pain.

P304

65-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PAIN.2009.01.022

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24034962

http://www.w3.org/2001/XMLSchema#string

P698

19237249

http://www.w3.org/2001/XMLSchema#string

P921

P932

2680088

http://www.w3.org/2001/XMLSchema#string